Roche Bobois S.A.S [RBO] vs SEB S.A [SK] Detailed Stock Comparison

Roche Bobois S.A.S.

EURONEXT
Loading...

SEB S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Roche Bobois S.A.S. wins in 6 metrics, SEB S.A. wins in 11 metrics, with 0 ties. SEB S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Roche Bobois S.A.S. SEB S.A. Better
P/E Ratio (TTM) 20.08 11.94 SEB S.A.
Price-to-Book Ratio 3.03 0.90 SEB S.A.
Debt-to-Equity Ratio 2.13 99.54 Roche Bobois S.A.S.
PEG Ratio 22.50 N/A N/A
EV/EBITDA 6.20 7.87 Roche Bobois S.A.S.
Profit Margin (TTM) 2.53% 2.99% SEB S.A.
Operating Margin (TTM) 4.82% 9.91% SEB S.A.
EBITDA Margin (TTM) 4.82% 9.91% SEB S.A.
Return on Equity 10.64% 8.06% Roche Bobois S.A.S.
Return on Assets (TTM) 2.31% 3.62% SEB S.A.
Free Cash Flow (TTM) $50.42M $-17.20M Roche Bobois S.A.S.
Dividend Yield 6.67% 3.45% Roche Bobois S.A.S.
1-Year Return -36.97% 13.80% SEB S.A.
Price-to-Sales Ratio (TTM) 0.65 0.36 SEB S.A.
Enterprise Value $417.82M $5.36B SEB S.A.
EV/Revenue Ratio 1.04 0.66 SEB S.A.
Revenue per Share (TTM) N/A $149 N/A
Earnings per Share (Diluted) $1.30 $4.45 SEB S.A.
Beta (Stock Volatility) 0.57 1.14 Roche Bobois S.A.S.

Roche Bobois S.A.S. vs SEB S.A. Stock Performance Analysis

Loading Price Chart...

RBO
SK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Roche Bobois S.A.S.-0.40%-4.55%0.80%-3.08%-30.00%-18.97%
SEB S.A.2.52%-1.49%-4.09%13.11%13.11%13.11%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Roche Bobois S.A.S.-36.97%-41.88%15.45%27.00%27.00%27.00%
SEB S.A.13.80%13.80%13.80%13.80%13.80%13.80%

Performance & Financial Health Analysis: Roche Bobois S.A.S. vs SEB S.A.

MetricRBOSK
Market Information
Market Cap i€262.78M€2.75B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i39969,357
90 Day Avg. Volume i83694,381
Last Close€25.10€50.05
52 Week Range€22.80 - €41.30€40.84 - €86.20
% from 52W High-39.23%-41.94%
All-Time High€55.20 (Aug 07, 2023)€175.90 (Jan 15, 2018)
% from All-Time High-54.53%-71.55%
Growth Metrics
Quarterly Revenue Growth-0.06%-0.02%
Quarterly Earnings Growth-0.41%0.85%
Financial Health
Profit Margin (TTM) i0.03%0.03%
Operating Margin (TTM) i0.05%0.10%
Return on Equity (TTM) i0.11%0.08%
Debt to Equity (MRQ) i2.1399.54
Cash & Liquidity
Book Value per Share (MRQ)€8.61€59.06
Cash per Share (MRQ)N/A€19.87
Operating Cash Flow (TTM) i€25.44M€204.40M
Levered Free Cash Flow (TTM) i€10.07M€236.04M
Dividends
Last 12-Month Dividend Yield i6.67%3.45%
Last 12-Month Dividend i€2.50€2.80

Valuation & Enterprise Metrics Analysis: Roche Bobois S.A.S. vs SEB S.A.

MetricRBO (Apr 24, 2026)SK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i20.0811.94
Forward P/E i22.506.71
PEG Ratio i22.50N/A
Price to Sales (TTM) i0.650.36
Price to Book (MRQ) i3.030.90
Market Capitalization
Market Capitalization i€262.78M€2.75B
Enterprise Value i€417.82M€5.36B
Enterprise Value Metrics
Enterprise to Revenue i1.040.66
Enterprise to EBITDA i6.207.87
Risk & Other Metrics
Beta i0.571.14
Book Value per Share (MRQ) i€8.61€59.06

Financial Statements Comparison: Roche Bobois S.A.S. vs SEB S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRBO (2025)SK (2025)
Revenue/Sales i402.51M8.17B
Cost of Goods Sold i141.04M4.88B
COGS % of Revenue i35.0%59.7%
Gross Profit i261.47M3.29B
Gross Margin i65.0%40.3%
Research & Development i1.58M181.40M
Operating Income (EBIT) i21.81M582.90M
Operating Margin i5.4%7.1%
EBITDA i67.41M833.10M
EBITDA Margin i16.7%10.2%
Pre-Tax Income i14.04M370.00M
Pre-Tax Income % of Revenue i3.5%4.5%
Income Tax i3.84M87.30M
Income Tax % of Revenue i1.0%1.1%
Net Income (Profit) i10.20M282.70M
Profit Margin i2.5%3.5%

Balance Sheet & Liquidity Metrics

MetricRBO (2025)SK (2025)
Cash & Equivalents i46.85M999.00M
Total Current Assets i176.18M4.24B
Total Current Assets % of Revenue i43.8%51.9%
Total Current Liabilities i194.69M3.35B
Total Current Liabilities % of Revenue i48.4%41.0%
Long-Term Debt i139.71M2.07B
Long-Term Debt % of Revenue i34.7%25.4%
Total Shareholders Equity i94.62M3.48B
Retained Earnings iN/AN/A
Retained Earnings % of Revenue i0.0%0.0%
Property, Plant & Equipment i152.45M477.50M

Cash Flow Statement Comparison

MetricRBO (2025)SK (2025)
Operating Cash Flow i25.44M57.20M
Operating Cash Flow % of Revenue i6.3%0.7%
Capital Expenditures i-11.69M-182.10M
Free Cash Flow i50.42M-17.20M
FCF Margin i12.5%-0.2%
Debt Repayment i-69.13M-1.26B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricRBOSK
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.07M54.79M
Float Shares iN/A36.42M
% Held by Insiders i88.46%46.48%
% Held by Institutions i1.50%32.04%
% Held by Public i10.04%21.48%

Dividend Analysis & Yield Comparison: Roche Bobois S.A.S. vs SEB S.A.

MetricRBOSK
Last 12-Month Dividend i€2.50€2.80
Last 12-Month Dividend Yield i6.67%3.45%
3-Year Avg Annual Dividend i€1.92€2.62
3-Year Avg Dividend Yield i2.75%2.13%
3-Year Total Dividends i€5.75€7.87
Ex-Dividend DateJul 02, 2025Jun 03, 2025